| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 7.816 | EUR 0 | |
| DIA.MI - DiaSorin SpA | SELL | -20 @ EUR 90.76 | EUR -1,815 | The ETF sold 20 shares of DIA.MI on 2025-04-07. The shares were previously bought for an average price of EUR 99.7953. The DiaSorin SpA shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 181 (USD $198) |
| AMP.MI - Amplifon SpA | SELL | -109 @ EUR 17.33 | EUR -1,889 | The ETF sold 109 shares of AMP.MI on 2025-04-07. The shares were previously bought for an average price of EUR 23.7778. The Amplifon SpA shares were sold for -27.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 703 (USD $772) |
| DEMANT.CO - | SELL | -78 @ DKK 29.3128 | DKK -2,286 | The ETF sold 78 shares of DEMANT.CO on 2025-04-07. The shares were previously bought for an average price of DKK 34.8311. The shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of DKK 430 (USD $63) |
| HIK.L - | SELL | -145 @ GBP 20.9498 | GBP -3,038 | The ETF sold 145 shares of HIK.L on 2025-04-07. The shares were previously bought for an average price of GBP 24.7096. The shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of GBP 545 (USD $704) |
| ZEAL.CO - | SELL | -56 @ DKK 54.9815 | DKK -3,079 | The ETF sold 56 shares of ZEAL.CO on 2025-04-07. The shares were previously bought for an average price of DKK 84.43. The shares were sold for -34.9% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,649 (USD $243) |
| IPN.PA - Ipsen SA | SELL | -33 @ EUR 98 | EUR -3,234 | The ETF sold 33 shares of IPN.PA on 2025-04-07. The shares were previously bought for an average price of EUR 110.194. The Ipsen SA shares were sold for -11.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 402 (USD $442) |
| DIM.PA - Sartorius Stedim Biotech | SELL | -25 @ EUR 152.9 | EUR -3,823 | The ETF sold 25 shares of DIM.PA on 2025-04-07. The shares were previously bought for an average price of EUR 188.505. The Sartorius Stedim Biotech shares were sold for -18.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 890 (USD $978) |
| BIM.PA - BioMerieux | SELL | -36 @ EUR 110.1 | EUR -3,964 | The ETF sold 36 shares of BIM.PA on 2025-04-07. The shares were previously bought for an average price of EUR 108.075. The BioMerieux shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of EUR 73 (USD $80) |
| SRT3.DE - Sartorius AG | SELL | -23 @ EUR 175.85 | EUR -4,045 | The ETF sold 23 shares of SRT3.DE on 2025-04-07. The shares were previously bought for an average price of EUR 223.995. The Sartorius AG shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,107 (USD $1,216) |
| SOBI.ST - | SELL | -171 @ SEK 23.8771 | SEK -4,083 | The ETF sold 171 shares of SOBI.ST on 2025-04-07. The shares were previously bought for an average price of SEK 27.1865. The shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of SEK 566 (USD $57) |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -100 @ EUR 46.36 | EUR -4,636 | The ETF sold 100 shares of REC.MI on 2025-04-07. The shares were previously bought for an average price of EUR 52.8916. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -12.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 653 (USD $717) |
| ORNBV.HE - Orion Oyj | SELL | -94 @ EUR 49.92 | EUR -4,692 | The ETF sold 94 shares of ORNBV.HE on 2025-04-07. The shares were previously bought for an average price of EUR 47.9221. The Orion Oyj shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of EUR 188 (USD $206) |
| ERF.PA - Eurofins Scientific SE | SELL | -117 @ EUR 46 | EUR -5,382 | The ETF sold 117 shares of ERF.PA on 2025-04-07. The shares were previously bought for an average price of EUR 49.0189. The Eurofins Scientific SE shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 353 (USD $388) |
| QIA.DE - QIAGEN NV | SELL | -187 @ EUR 36.145 | EUR -6,759 | The ETF sold 187 shares of QIA.DE on 2025-04-07. The shares were previously bought for an average price of EUR 36.5768. The QIAGEN NV shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 81 (USD $89) |
| GALD.SW - | SELL | -82 @ CHF 83.2214 | CHF -6,824 | The ETF sold 82 shares of GALD.SW on 2025-04-07. The shares were previously bought for an average price of CHF 97.4302. The shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of CHF 1,165 (USD $1,368) |
| FME.DE - Fresenius Medical Care AG | SELL | -179 @ EUR 42.18 | EUR -7,550 | The ETF sold 179 shares of FME.DE on 2025-04-07. The shares were previously bought for an average price of EUR 44.5368. The Fresenius Medical Care AG shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 422 (USD $463) |
| RO.SW - | SELL | -28 @ CHF 278.467 | CHF -7,797 | The ETF sold 28 shares of RO.SW on 2025-04-07. The shares were previously bought for an average price of CHF 306.98. The shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 798 (USD $937) |
| SN.L - Smith & Nephew PLC | SELL | -720 @ GBP 11.4372 | GBP -8,235 | The ETF sold 720 shares of SN.L on 2025-04-07. The shares were previously bought for an average price of GBP 13.1828. The Smith & Nephew PLC shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of GBP 1,257 (USD $1,623) |
| GMAB.CO - | SELL | -54 @ DKK 165.32 | DKK -8,927 | The ETF sold 54 shares of GMAB.CO on 2025-04-07. The shares were previously bought for an average price of DKK 197.126. The shares were sold for -16.1% lower than average price of previous purchases. This resulted in an overall loss of DKK 1,718 (USD $253) |
| STMN.SW - | SELL | -97 @ CHF 96.8259 | CHF -9,392 | The ETF sold 97 shares of STMN.SW on 2025-04-07. The shares were previously bought for an average price of CHF 121.688. The shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,412 (USD $2,832) |
| COLO-B.CO - | SELL | -109 @ DKK 91.1535 | DKK -9,936 | The ETF sold 109 shares of COLO-B.CO on 2025-04-07. The shares were previously bought for an average price of DKK 100.135. The shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of DKK 979 (USD $144) |
| SHL.DE - Siemens Healthineers AG | SELL | -243 @ EUR 43.24 | EUR -10,507 | The ETF sold 243 shares of SHL.DE on 2025-04-07. The shares were previously bought for an average price of EUR 51.7393. The Siemens Healthineers AG shares were sold for -16.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,065 (USD $2,269) |
| SOON.SW - | SELL | -44 @ CHF 242.118 | CHF -10,653 | The ETF sold 44 shares of SOON.SW on 2025-04-07. The shares were previously bought for an average price of CHF 303.998. The shares were sold for -20.4% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,723 (USD $3,197) |
| SDZ.SW - | SELL | -361 @ CHF 33.5117 | CHF -12,098 | The ETF sold 361 shares of SDZ.SW on 2025-04-07. The shares were previously bought for an average price of CHF 39.9728. The shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,332 (USD $2,739) |
| MRK.DE - Merck KGaA | SELL | -112 @ EUR 112.7 | EUR -12,622 | The ETF sold 112 shares of MRK.DE on 2025-04-07. The shares were previously bought for an average price of EUR 137.277. The Merck KGaA shares were sold for -17.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,753 (USD $3,024) |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -365 @ EUR 36.12 | EUR -13,184 | The ETF sold 365 shares of FRE.DE on 2025-04-07. The shares were previously bought for an average price of EUR 35.6746. The Fresenius SE & Co KGaA shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of EUR 163 (USD $179) |
| PHIA.AS - Koninklijke Philips NV | SELL | -691 @ EUR 20.07 | EUR -13,868 | The ETF sold 691 shares of PHIA.AS on 2025-04-07. The shares were previously bought for an average price of EUR 24.4258. The Koninklijke Philips NV shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of EUR 3,010 (USD $3,306) |
| UCB.BR - UCB SA | SELL | -109 @ EUR 144.05 | EUR -15,701 | The ETF sold 109 shares of UCB.BR on 2025-04-07. The shares were previously bought for an average price of EUR 181.816. The UCB SA shares were sold for -20.8% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,116 (USD $4,522) |
| BAYN.DE - Bayer AG | SELL | -849 @ EUR 19.832 | EUR -16,837 | The ETF sold 849 shares of BAYN.DE on 2025-04-07. The shares were previously bought for an average price of EUR 21.0786. The Bayer AG shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 1,058 (USD $1,163) |
| ARGX.BR - Argenx SE | SELL | -52 @ EUR 498.4 | EUR -25,917 | The ETF sold 52 shares of ARGX.BR on 2025-04-07. The shares were previously bought for an average price of EUR 578.845. The Argenx SE shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,183 (USD $4,595) |
| LONN.SW - | SELL | -62 @ CHF 514.952 | CHF -31,927 | The ETF sold 62 shares of LONN.SW on 2025-04-07. The shares were previously bought for an average price of CHF 575.065. The shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of CHF 3,727 (USD $4,376) |
| ALC.SW - | SELL | -432 @ CHF 74.3997 | CHF -32,141 | The ETF sold 432 shares of ALC.SW on 2025-04-07. The shares were previously bought for an average price of CHF 82.9595. The shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 3,698 (USD $4,342) |
| HLN.L - Haleon PLC | SELL | -7,827 @ GBP 4.16428 | GBP -32,594 | The ETF sold 7827 shares of HLN.L on 2025-04-07. The shares were previously bought for an average price of GBP 4.70251. The Haleon PLC shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of GBP 4,213 (USD $5,439) |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,583 @ GBP 15.5489 | GBP -55,712 | The ETF sold 3583 shares of GSK.L on 2025-04-07. The shares were previously bought for an average price of GBP 16.8573. The GlaxoSmithKline PLC shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of GBP 4,688 (USD $6,052) |
| EL.PA - EssilorLuxottica SA | SELL | -257 @ EUR 232.9 | EUR -59,855 | The ETF sold 257 shares of EL.PA on 2025-04-07. The shares were previously bought for an average price of EUR 250.052. The EssilorLuxottica SA shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,408 (USD $4,842) |
| SAN.PA - Sanofi SA | SELL | -983 @ EUR 91.41 | EUR -89,856 | The ETF sold 983 shares of SAN.PA on 2025-04-07. The shares were previously bought for an average price of EUR 98.2822. The Sanofi SA shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 6,755 (USD $7,420) |
| AZN.L - AstraZeneca PLC | SELL | -1,341 @ GBP 117.431 | GBP -157,475 | The ETF sold 1341 shares of AZN.L on 2025-04-07. The shares were previously bought for an average price of GBP 131.465. The AstraZeneca PLC shares were sold for -10.7% lower than average price of previous purchases. This resulted in an overall loss of GBP 18,820 (USD $24,296) |
| NOVN.SW - | SELL | -1,704 @ CHF 92.5957 | CHF -157,783 | The ETF sold 1704 shares of NOVN.SW on 2025-04-07. The shares were previously bought for an average price of CHF 98.0225. The shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of CHF 9,247 (USD $10,859) |
| ROG.SW - | SELL | -607 @ CHF 261.568 | CHF -158,772 | The ETF sold 607 shares of ROG.SW on 2025-04-07. The shares were previously bought for an average price of CHF 290.255. The shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 17,413 (USD $20,447) |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -2,784 @ DKK 58.1499 | DKK -161,889 | The ETF sold 2784 shares of NOVO-B.CO on 2025-04-07. The shares were previously bought for an average price of DKK 74.4034. The Novo Nordisk A/S shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of DKK 45,250 (USD $6,660) |